Proliferative cell nuclear antigen in postradiotherapy prostate biopsies
- 1 September 1994
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 30 (2) , 303-308
- https://doi.org/10.1016/0360-3016(94)90008-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Cell Proliferation in Prostatic Adenocarcinoma: In Vitro Measurement by 5-Bromodeoxyuridine Incorporation and Proliferating Cell Nuclear Antigen ExpressionJournal of Urology, 1993
- Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parametersThe Prostate, 1992
- Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen LevelsJournal of Urology, 1991
- Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-upRadiotherapy and Oncology, 1990
- Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostatesCancer, 1989
- A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United StatesInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Potential for radiotherapy alone in prostatic cancerCancer, 1985
- Radiation injury of the normal and neoplastic prostateThe American Journal of Surgical Pathology, 1982
- Significance of prostatic biopsies after radiation therapy for carcinoma of the prostateThe Prostate, 1982